Wick Capital Partners LLC Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Wick Capital Partners LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 15.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 555 shares of the healthcare conglomerate’s stock after acquiring an additional 74 shares during the quarter. Wick Capital Partners LLC’s holdings in UnitedHealth Group were worth $280,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $30,000. Finally, AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH opened at $296.45 on Friday. The stock has a 50 day moving average price of $456.57 and a 200 day moving average price of $506.94. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $268.92 billion, a price-to-earnings ratio of 19.13, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the company earned $6.91 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 2.83%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on UNH shares. Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Hsbc Global Res lowered shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday. Oppenheimer dropped their target price on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research report on Wednesday, May 14th. Raymond James downgraded UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research report on Monday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $441.87.

Insider Transactions at UnitedHealth Group

In other news, Director Kristen Gil purchased 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the company’s stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 over the last 90 days. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.